“Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)” (2019) SKIN The Journal of Cutaneous Medicine, 3, p. S37. doi:10.25251/skin.3.supp.37.